Skip to main content

Table 1 Characteristics of the population studied

From: Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study

Sex

  Male

5

  Female

14

Age (years)

  Mean

25.1

  Median

25

  Range

19-32

Disease (years)

  Mean

3,1

  Median

3